WO2025220405A1 - Composite particles and method for producing same - Google Patents
Composite particles and method for producing sameInfo
- Publication number
- WO2025220405A1 WO2025220405A1 PCT/JP2025/010818 JP2025010818W WO2025220405A1 WO 2025220405 A1 WO2025220405 A1 WO 2025220405A1 JP 2025010818 W JP2025010818 W JP 2025010818W WO 2025220405 A1 WO2025220405 A1 WO 2025220405A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composite particles
- group
- particles
- carboxy group
- composite
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
- G01N33/548—Carbohydrates, e.g. dextran
Definitions
- the present invention relates to composite particles containing cellulose nanofibers and magnetic particles, a method for producing the same, and a method for capturing or detecting a target compound using the composite particles.
- Cellulose nanofibers are nano-sized cellulose fibers obtained by defibrating cellulose-based raw materials such as wood. Cellulose nanofibers are known to be used as adsorbents and carriers for biologically active substances such as proteins.
- Patent Document 1 discloses that cellulose/magnetic material composite particles are obtained by spray-drying a dispersion containing cellulose nanofibers and magnetic material particles, thereby improving the collectability of cellulose particles made of cellulose nanofibers.
- physiologically active substances are separated and purified by non-specifically adsorbing them to cellulose nanofibers containing carboxy groups. Therefore, it is not possible to capture or detect specific target compounds such as antigens using specific binding, such as an antigen-antibody reaction.
- specific target compounds such as antigens using specific binding, such as an antigen-antibody reaction.
- the present invention aims to provide composite particles of cellulose nanofibers and magnetic particles into which a carboxy group-containing compound can be introduced, and a method for producing the same.
- the present invention aims to provide novel composite particles in which a carboxy group-containing compound has been introduced into composite particles of cellulose nanofibers and magnetic particles, a method for producing the same, and a method for using the same.
- the present invention includes the embodiments shown below.
- R 1 represents a single bond or a divalent aliphatic group having 1 to 10 carbon atoms.
- a method for producing the composite particles according to [1] or [2], Composite particles containing cellulose nanofibers having carboxy groups and magnetic particles; hydrazine or an aliphatic diamine, at least one condensing agent selected from the group consisting of carbodiimide-based condensing agents, imidazole-based condensing agents, triazine-based condensing agents, phosphonium-based condensing agents, uronium-based condensing agents, and haluronium-based condensing agents; in an organic solvent.
- [7] A method for producing composite particles having a carboxy group-containing compound introduced therein, comprising reacting the carboxy group of a carboxy group-containing compound with —NH 2 of the group represented by the general formula (1) contained in the composite particles according to [1] or [2]. [8] The method for producing composite particles according to [7], wherein the carboxy group-containing compound is biotin or a protein.
- a method for capturing or detecting a target compound comprising mixing the composite particle described in [4] with a target compound that specifically binds to the biotin or the protein in a liquid, thereby binding the biotin or the protein to the target compound.
- a carboxy group-containing compound can be introduced into composite particles containing cellulose nanofibers and magnetic particles using the amino groups introduced into the cellulose nanofibers. Furthermore, novel composite particles into which a carboxy group-containing compound has been introduced can be provided, which can be used, for example, to capture or detect specific target compounds.
- Composite particles (A) contain cellulose nanofibers modified with amino groups and magnetic particles.
- the composite particles (A) are cellulose particles made of cellulose nanofibers combined with magnetic particles.
- the magnetic particles are integrated into a composite in a dispersed state with the cellulose nanofibers, and may be attached to the particle surface of the cellulose particles made of cellulose nanofibers or embedded inside.
- the magnetic particles are not particularly limited as long as they are particles made of a ferromagnetic material that can be attracted by a magnet, and examples include particles of metal oxides such as iron oxides such as Fe 3 O 4 and ⁇ -Fe 2 O 3, metals such as iron, manganese, nickel, cobalt, and chromium, or alloys thereof, metal salts such as various ferrites, ferritic or martensitic stainless steel, amorphous alloys, and silicon-iron soft magnetic crystals, and any one of these can be used alone or in combination of two or more.
- metal oxides such as iron oxides such as Fe 3 O 4 and ⁇ -Fe 2 O 3
- metals such as iron, manganese, nickel, cobalt, and chromium, or alloys thereof
- metal salts such as various ferrites, ferritic or martensitic stainless steel, amorphous alloys, and silicon-iron soft magnetic crystals, and any one of these can be used alone or in combination of two or more.
- the average particle size of the magnetic particles is not particularly limited, but is preferably 1 to 500 nm, more preferably 2 to 300 nm, more preferably 5 to 200 nm, more preferably 7 to 100 nm, and even more preferably 10 to 50 nm.
- the cellulose nanofibers have (a) a number-average fiber diameter of 3 nm or more and 100 nm or less, (b) a cellulose type I crystal structure, and (c) an average aspect ratio of 2 or more and 5,000 or less.
- the number average fiber diameter of (a) above is more preferably 50 nm or less, even more preferably 30 nm or less, and may be 10 nm or less.
- the number average fiber diameter can be measured as follows.
- an aqueous dispersion of cellulose nanofibers with a solid content of 0.05 to 0.1% by mass is prepared, and this aqueous dispersion is cast onto a hydrophilically treated carbon film-coated grid to prepare a sample for observation with a transmission electron microscope (TEM). If the sample contains fibers with large diameters, a scanning electron microscope (SEM) image of the surface cast onto glass may be observed. The observation sample may also be negatively stained, for example, with 2% by mass uranyl acetate. The electron microscope image is then observed at a magnification of 5,000x, 10,000x, or 50,000x, depending on the size of the fibers.
- TEM transmission electron microscope
- an arbitrary axis of vertical or horizontal width is assumed within the obtained image, and the sample and observation conditions (magnification, etc.) are adjusted so that 20 or more fibers intersect with this axis.
- two random axes are drawn vertically and horizontally on the image, and the fiber diameters of the fibers intersecting the axes are visually determined.
- the arithmetic mean of the fiber diameters obtained in this way is taken as the number average fiber diameter.
- the average aspect ratio of (c) above is more preferably 50 to 1000, even more preferably 100 to 500, and may be 200 to 400.
- the average aspect ratio can be measured as follows.
- the number-average fiber diameter is calculated according to the method described above.
- Cellulose nanofibers modified with amino groups are cellulose nanofibers having a group represented by the following general formula (1) (hereinafter referred to as "functional group (1)").
- R 1 in formula (1) represents a single bond or a divalent aliphatic group having 1 to 10 carbon atoms.
- the divalent aliphatic group may be a saturated aliphatic group or an unsaturated aliphatic group, but is preferably a saturated aliphatic group (i.e., an alkanediyl group).
- the alkanediyl group may be linear or branched, but is preferably linear.
- the number of carbon atoms in the divalent aliphatic group is more preferably 2 to 8, and even more preferably 2 to 6.
- cellulose nanofibers modified with amino groups are obtained by subjecting the carboxy groups of carboxy group-containing cellulose nanofibers to a dehydration condensation reaction with the amino groups of hydrazine or an aliphatic diamine.
- Carboxy group-containing cellulose nanofibers are cellulose nanofibers that have carboxy groups, and examples include oxidized cellulose nanofibers formed by oxidizing the hydroxyl groups of the glucose units in cellulose molecules, and carboxymethylated cellulose nanofibers formed by carboxymethylating the hydroxyl groups of the glucose units in cellulose molecules.
- Oxidized cellulose nanofibers include those in which the hydroxyl group at the C6 position of the glucose unit in the cellulose molecule has been selectively oxidized to a carboxyl group. These oxidized cellulose nanofibers are obtained by oxidizing natural cellulose, such as wood pulp, using a co-oxidant in the presence of an N-oxyl compound and then defibrating (refining) it.
- the N-oxyl compound used is a compound containing a nitroxy radical, which is commonly used as an oxidation catalyst.
- a piperidine nitroxyoxy radical is used. 2,2,6,6-tetramethylpiperidinoxy radical (TEMPO) or 4-acetamido-TEMPO is particularly preferred.
- TEMPO 2,2,6,6-tetramethylpiperidinoxy radical
- 4-acetamido-TEMPO is particularly preferred.
- Oxidized cellulose nanofibers may also contain aldehyde or ketone groups in addition to the carboxyl groups.
- Carboxy group-containing cellulose nanofibers may be obtained by defibration treatment.
- the defibration treatment may be carried out after or before the introduction of carboxy groups.
- the defibration treatment can be carried out by processing a dispersion of cellulose fibers using, for example, a homomixer, high-pressure homogenizer, ultrasonic dispersion processor, beater, disk refiner, conical refiner, double-disc refiner, grinder, etc. at high speed, and a dispersion of cellulose nanofibers can be obtained.
- the amount of carboxy groups in the carboxy group-containing cellulose nanofibers is not particularly limited, and may be, for example, 0.5 to 3.0 mmol/g or 1.5 to 2.0 mmol/g per dry mass of the carboxy group-containing cellulose nanofibers.
- the amount of carboxy groups can be determined according to the following formula: 60 mL of a cellulose nanofiber-containing slurry adjusted to a concentration of 0.1 to 1 mass % is prepared, the pH is adjusted to about 2.5 with a 0.1 mol/L aqueous hydrochloric acid solution, a 0.05 mol/L aqueous sodium hydroxide solution is added dropwise, and electrical conductivity is measured, continuing until the pH reaches about 11, and the amount of sodium hydroxide (V) consumed in the neutralization stage of the weak acid, where the change in electrical conductivity is gradual, is used.
- Amount of carboxyl group (mmol/g) V (mL) ⁇ [0.05/mass of cellulose nanofiber (g)]
- Aliphatic diamines with 1 to 10 carbon atoms are used as the aliphatic diamines to be reacted with the carboxyl group-containing cellulose nanofibers, thereby introducing functional group (1) into the cellulose nanofibers.
- the aliphatic diamine preferably has 2 to 8 carbon atoms, and more preferably 2 to 6 carbon atoms.
- alkylenediamines saturated aliphatic diamines are preferred, alkylenediamines are more preferred, and straight-chain alkylenediamines are even more preferred.
- alkylenediamines include ethylenediamine, propylenediamine, trimethylenediamine, tetramethylenediamine, pentamethylenediamine, and hexamethylenediamine, and any of these may be used alone or in combination of two or more.
- Functional group (1) may be introduced to all or some of the carboxy groups of the carboxy group-containing cellulose nanofibers.
- the amount of functional group (1) is not particularly limited, and may be, for example, 0.5 to 3.0 mmol/g or 1.5 to 2.0 mmol/g per dry mass of cellulose nanofibers having functional group (1), similar to the amount of carboxy groups described above.
- the ratio of cellulose nanofibers having functional groups (1) to magnetic particles is not particularly limited, and the mass ratio M/C of magnetic particles (M) to cellulose nanofibers (C) may be 0.01 to 10, 0.05 to 2, 0.08 to 1, or 0.1 to 0.5.
- the composite particles (A) are preferably micro-sized from the standpoint of ease of handling. More specifically, the average particle size of the composite particles may be 1 to 30 ⁇ m, 1 to 20 ⁇ m, or 2 to 15 ⁇ m.
- the composite particles (A) are formed from cellulose nanofibers and magnetic particles, and may consist solely of cellulose nanofibers and magnetic particles, but may also contain other components.
- the method for producing the composite particles (A) can be produced by a method comprising spray-drying a dispersion containing carboxyl group-containing cellulose nanofibers and magnetic particles (Step 1), and reacting the carboxyl groups of the cellulose nanofibers contained in the composite particles obtained by spray-drying with hydrazine or an aliphatic diamine (Step 2).
- step 1 spray drying the dispersion liquid allows for the production of a dry powder without agglomerating the cellulose nanofibers, thereby enabling the cellulose nanofibers and magnetic particles to be composited.
- the dispersion liquid used for spray drying is prepared, for example, by using water as a solvent and uniformly mixing and dispersing the cellulose nanofibers and magnetic particles in the solvent.
- the concentration of cellulose nanofibers in the dispersion liquid is not particularly limited as long as cellulose particles can be formed by spray drying, and may be, for example, 0.005 to 5% by mass or 0.01 to 1% by mass.
- the concentration of magnetic particles is also not particularly limited, and may be, for example, 0.005 to 5% by mass or 0.01 to 1% by mass.
- the ratio of cellulose nanofibers to magnetic particles in the dispersion may be 0.01 to 10, 0.05 to 2, 0.08 to 1, or 0.1 to 0.5, in terms of the mass ratio M/C of magnetic particles (M) to cellulose nanofibers (C).
- Spray drying is a method of producing dry powder by spraying a dispersion into a gas and rapidly drying it, and can be carried out using a known spray dryer. There are no particular restrictions on the drying temperature in spray drying, and it can be, for example, 150 to 200°C.
- the dispersion liquid used for spray drying may contain a crosslinking agent that reacts with carboxy groups.
- a crosslinking agent By including a crosslinking agent, the carboxy groups of the cellulose nanofibers react with the crosslinking agent during the spray drying process, resulting in composite particles with a crosslinked structure. This allows the composite particles to retain their shape well when redispersed in a liquid such as water, improving durability.
- the crosslinking agent is not particularly limited, and examples include amino resins, epoxy compounds, aziridine compounds, carbodiimide compounds, oxazoline compounds, polyisocyanate compounds, etc.
- step 2 the method for reacting hydrazine or aliphatic diamine is not particularly limited, as long as it allows the carboxy groups of the carboxy group-containing cellulose nanofibers and the amino groups of the hydrazine or aliphatic diamine to form amide bonds through dehydration condensation.
- step 2a it is preferable to include a step (step 2a) of mixing the composite particles obtained by the above-mentioned spray drying with hydrazine or aliphatic diamine and a condensing agent in an organic solvent. This allows functional group (1) to be introduced more efficiently into the carboxy groups on the particle surface.
- the condensing agent may be at least one selected from the group consisting of carbodiimide condensing agents, imidazole condensing agents, triazine condensing agents, phosphonium condensing agents, uronium condensing agents, and haluronium condensing agents.
- carbodiimide condensing agents examples include 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride, N,N'-dicyclohexylcarbodiimide, and N,N'-diisopropylcarbodiimide.
- imidazole-based condensing agents examples include N,N'-carbonyldiimidazole and 1,1'-carbonyldi(1,2,4-triazole).
- triazine-based condensing agents examples include 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride n-hydrate and (4,6-dimethoxy-1,3,5-triazin-2-yl)-(2-octoxy-2-oxoethyl)dimethylammonium trifluoromethanesulfonate.
- Examples of phosphonium condensing agents include 1H-benzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluorophosphate, 1H-benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate, (7-azabenzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate, chlorotripyrrolidinophosphonium hexafluorophosphate, bromotris(dimethylamino)phosphonium hexafluorophosphate, and 3-(diethoxyphosphoryloxy)-1,2,3-benzotriazin-4(3H)-one.
- uronium-based condensing agents examples include O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate, O-(7-azabenzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate, O-(N-succinimidyl)-N,N,N',N'-tetramethyluronium tetrafluoroborate, O-(N-succinimidyl)-N,N,N',N'-tetramethyluronium hexafluorophosphate, O-(3,4-dihydro-4-oxo -1,2,3-benzotriazin-3-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate, S-(1-oxido-2-pyridyl)-N
- halouronium condensing agents examples include 2-chloro-1,3-dimethylimidazolinium hexafluorophosphate, 1-(chloro-1-pyrrolidinylmethylene)pyrrolidinium hexafluorophosphate, 2-fluoro-1,3-dimethylimidazolinium hexafluorophosphate, and fluoro-N,N,N',N'-tetramethylformamidinium hexafluorophosphate.
- These condensing agents may be used alone or in combination of two or more.
- the organic solvent is not particularly limited, but examples include dimethylformamide, dimethyl sulfoxide, tetrahydrofuran, dichloromethane, acetone, chloroform, toluene, 1,2-dichloroethane, 1,4-dioxane, and ethyl acetate.
- the amount of hydrazine or aliphatic diamine is not particularly limited, and may be added in an amount equal to or greater than the amount of carboxy groups in the cellulose nanofibers that make up the composite particles, for example.
- the amount of condensing agent is also not particularly limited, and may be added in an amount equal to or greater than the amount of carboxy groups in the cellulose nanofibers that make up the composite particles, for example.
- the composite particle (B) is a composite particle containing cellulose nanofibers and magnetic particles, to which a carboxy group-containing compound has been introduced.
- the composite particle (B) contains a carboxy group-containing compound bound to the cellulose nanofibers via an amide bond, which is a structure formed by dehydration condensation between the -NH2 of the functional group (1) introduced into the composite particle (A) and the carboxy group of the carboxy group-containing compound.
- the composite particles (A) have a primary amino group (—NH 2 ), they can react with a carboxyl group-containing compound such as a protein to form an amide bond. This makes it possible to easily obtain composite particles (B) into which a carboxyl group-containing compound has been introduced. Therefore, the composite particles (A) are suitable for use as precursors for bonding a carboxyl group-containing compound such as a protein.
- carboxyl group-containing compounds include biotin and proteins.
- proteins include antibodies, peptides, protein A, protein G, protein L, streptavidin, and enzymes.
- carboxy group-containing compounds may have their carboxy groups converted into active esters, and the concept of the carboxy group of a carboxy group-containing compound encompasses such active esterified active ester groups.
- the method for converting into an active ester is not particularly limited, and examples include a method in which an additive such as N-hydroxysuccinimide, N,N'-disuccinimidyl carbonate, N-hydroxysulfosuccinimide alkali metal salt, 1-hydroxybenzotriazole, 1-hydroxy-7-azabenzotriazole, ethyl (hydroxyimino)cyanoacetate, pentafluorophenol, or nitrophenol is reacted with the carboxy group-containing compound using the condensing agent described above.
- an additive such as N-hydroxysuccinimide, N,N'-disuccinimidyl carbonate, N-hydroxysulfosuccinimide alkali metal salt, 1-hydroxybenzotriazole, 1-hydroxy-7-azabenzotri
- the carboxy group-containing compound is introduced into the composite particle (A) by mixing the composite particle (A), the carboxy group-containing compound, and the condensing agent in an organic solvent, thereby obtaining composite particle (B).
- the carboxy group of the carboxy group-containing compound is actively esterified, the carboxy group-containing compound is introduced into the composite particle (A) by mixing the composite particle (A) with the actively esterified carboxy group-containing compound in an organic solvent, thereby obtaining composite particle (B).
- the organic solvent used in these cases is not particularly limited, and examples include dimethylformamide, methyl sulfoxide, tetrahydrofuran, dichloromethane, acetone, chloroform, toluene, 1,2-dichloroethane, 1,4-dioxane, and ethyl acetate.
- the amount of the carboxy group-containing compound used is also not particularly limited, and may be added in an amount equal to or greater than the amount of primary amino groups in the cellulose nanofibers that make up the composite particle.
- Composite particles (B) with biotin or protein introduced in this manner are suitable for use in capturing or detecting target compounds that specifically bind to biotin or protein.
- examples of the target compound include avidin and streptavidin, which specifically bind to biotin.
- the target compound in the case of composite particles (B) with an antibody introduced as the protein, the target compound is an antigen that specifically binds to the antibody. In this way, specific target compounds can be captured or detected by utilizing avidin-biotin interactions or antigen-antibody reactions.
- a method for capturing or detecting a target compound involves mixing composite particles (B) into which biotin or protein has been introduced with a target compound that specifically binds to these particles in a liquid, thereby binding the biotin or protein to the target compound. More specifically, for example, the composite particles (B) are added to and mixed with a liquid that contains or is suspected of containing the target compound. This allows the target compound to specifically bind to the biotin or protein of the composite particles (B). The composite particles (B) to which the target compound has bound can then be collected (recovered) from the liquid in which the composite particles (B) are dispersed by magnetic separation using a magnet.
- a magnet When collecting composite particles (B) by magnetic separation, for example, when composite particles (B) are dispersed in a liquid, a magnet can be used to attract and collect the composite particles (B) to the wall of a container using its magnetic force, allowing them to be easily separated from the liquid.
- the magnet may be a permanent magnet or an electromagnet. Such collection of composite particles by magnetic separation can be used in a variety of situations.
- Examples include when washing composite particles before the amidation reaction in the method for producing composite particles (A), when separating and washing composite particles (A) from the reaction solution after the amidation reaction, when separating and washing composite particles (B) from the reaction solution after the introduction reaction in the step of introducing a carboxy group-containing compound, and when separating and washing composite particles (B) from the liquid after binding to the target compound in a method for capturing or detecting the target compound.
- the composite particles according to this embodiment may be used, for example, in sandwich ELISA.
- a composite particle (A) having a functional group (1) is reacted with an antibody (capture antibody) as a carboxy group-containing compound to produce a composite particle (B) incorporating the capture antibody.
- the composite particle (B) is then mixed with a liquid containing or suspected of containing an antigen as the target compound, causing the antigen to bind to the capture antibody.
- An enzyme-labeled antibody detection antibody
- detection antibody is then added, causing the detection antibody to bind to the antigen bound to the capture antibody.
- a chromogenic substrate, colorimetric substrate, or luminescent substrate for the enzyme is then added, causing a reaction to develop color, color, or light, and the intensity of the color, color, or light emission is measured, allowing the target compound to be quantitatively detected.
- the composite particles according to this embodiment may be used, for example, to detect avidin or streptavidin (hereinafter simply referred to as avidin) by utilizing the avidin-biotin interaction.
- biotin is introduced into composite particles (A) having functional group (1) by reacting them with biotin to produce composite particles (B).
- the composite particles (B) are mixed with a liquid containing or suspected of containing enzyme-labeled avidin as the target compound, thereby binding the biotin and enzyme-labeled avidin.
- a color-developing substrate, color-developing substrate, or luminescent substrate for the enzyme is then added and reacted to produce color, color, or light. The intensity of the color, color, or light emission is measured, allowing the target compound to be quantitatively detected.
- Amount of carboxyl groups in cellulose nanofibers 60 mL of an aqueous dispersion was prepared by dispersing 0.25 g of a sample in water, and the pH was adjusted to approximately 2.5 with 0.1 M aqueous hydrochloric acid solution. After that, 0.05 M aqueous sodium hydroxide solution was added dropwise, and electrical conductivity was measured, and the amount of carboxyl groups was determined according to the method described above.
- Average particle size of composite particles and magnetic particles Photographs were taken at a magnification of 5,000 to 20,000 times using an SEM (scanning electron microscope: S-5000, manufactured by Hitachi High-Technologies Corporation, 20 kV), and 200 or more particles were randomly selected, their diameters were measured, and the average value was calculated.
- SEM scanning electron microscope: S-5000, manufactured by Hitachi High-Technologies Corporation, 20 kV
- ultrasonic dispersion T10 ULTRA-TU RRAX S0004, manufactured by IKA Corporation
- the obtained aqueous dispersion was spray-dried using a spray dryer (Mini Spray Dryer B-290, manufactured by BUCHI Corporation) to crosslink the carboxy groups of the TOCN with the oxazoline-based crosslinking agent and simultaneously composite the TOCN with Fe 3 O 4 particles 1, thereby obtaining TOCN magnetic composite particles (TEFW-0.1-10) (average particle size: 2.73 ⁇ m) of Preparation Example 1.
- the spray drying was performed at an inlet temperature of 120°C, a liquid flow rate of 2.5 mL/min, and a gas flow rate of 6 L/min.
- Preparation Example 2 The amount of Fe 3 O 4 particles 1 added was adjusted so that the Fe 3 O 4 /TOCN (mass ratio) was 3/10, and the rest was the same as in Preparation Example 1 to obtain TOCN magnetic composite particles (TEFW-0.3-10) (average particle size: 2.92 ⁇ m) of Preparation Example 2.
- Preparation Example 3 The procedure was otherwise the same as in Preparation Example 1, except that Fe3O4 particles 2 were used instead of Fe3O4 particles 1, and the amount of Fe3O4 particles 2 added was adjusted so that the Fe3O4 / TOCN (mass ratio) was 1/1, to obtain TOCN magnetic composite particles (TEFW-1-300) (average particle size: 2.59 ⁇ m) of Preparation Example 3.
- the magnetic separation was performed by inserting the microtube into a magnet stand (manufactured by Tamagawa Seiki Co., Ltd.), allowing the TOCN magnetic composite particles in the dispersion to collect on the side of the microtube, and then removing the DMF.
- the washing procedure in (1) above was repeated three times.
- (3) 3.1 mg (16 ⁇ mol) of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDAC) was dissolved in 1 mL of DMF to prepare an EDAC solution.
- biotin-introduced composite particles were prepared according to the following procedures (1) to (3).
- magnetic separation and washing were performed three times using 1 mL of DMF.
- the magnetic separation and washing method was the same as in (1) of the method for preparing amino group-modified TOCN magnetic composite particles.
- composite particles with biotin incorporated were obtained, as shown in the following reaction formula.
- an avidin detection test was carried out according to the following procedures (1) to (7).
- the buffer used was 0.1 M glycine-NaOH buffer (pH 10.3) containing 1 mM MgCl , 0.1 mM ZnCl , and 0.025% ovalbumin.
- the washing procedure in (1) above was repeated three times.
- the biotin-introduced composite particles were divided into 0.2 mg portions, and 200 ⁇ L of streptavidin-ALP (Promega) diluted 5,000-fold, 10,000-fold, or 20,000-fold with the above buffer or buffer was added, and the mixture was mixed by inversion using a rotator at room temperature for 1 hour.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
Description
本発明は、セルロースナノファイバーと磁性体粒子とを含む複合粒子、及びその製造方法、並びに、該複合粒子を用いて対象化合物を捕集又は検出する方法に関する。 The present invention relates to composite particles containing cellulose nanofibers and magnetic particles, a method for producing the same, and a method for capturing or detecting a target compound using the composite particles.
セルロースナノファイバーは、木材などのセルロース系原料を解繊処理することにより得られるナノオーダーのセルロース繊維である。セルロースナノファイバーについて、タンパク質などの生理活性物質用の吸着剤や担体として用いることが知られている。 Cellulose nanofibers are nano-sized cellulose fibers obtained by defibrating cellulose-based raw materials such as wood. Cellulose nanofibers are known to be used as adsorbents and carriers for biologically active substances such as proteins.
例えば、特許文献1には、セルロースナノファイバーと磁性体粒子を含む分散液を噴霧乾燥することでセルロース/磁性体複合粒子を得ること、及び、それによりセルロースナノファイバーからなるセルロース粒子の収集性を向上することが開示されている。 For example, Patent Document 1 discloses that cellulose/magnetic material composite particles are obtained by spray-drying a dispersion containing cellulose nanofibers and magnetic material particles, thereby improving the collectability of cellulose particles made of cellulose nanofibers.
特許文献1に記載の複合粒子では、カルボキシ基を持つセルロースナノファイバーに生理活性物質を非特異的に吸着させることにより、生理活性物質の分離精製が行われる。そのため、抗原などの特定の対象化合物を抗原抗体反応などの特異的な結合を利用して捕集又は検出できるものではない。特定の対象化合物を捕集又は検出するためには、当該対象化合物と特異的に結合する抗体(タンパク質)などの物質をセルロースナノファイバーに導入する必要がある。そのような対象化合物と特異的に結合する物質として、例えばビオチンやタンパク質等のカルボキシ基含有化合物をセルロースナノファイバーに簡単に導入することができれば、上記複合粒子の利便性を向上することができると考えられる。 In the composite particles described in Patent Document 1, physiologically active substances are separated and purified by non-specifically adsorbing them to cellulose nanofibers containing carboxy groups. Therefore, it is not possible to capture or detect specific target compounds such as antigens using specific binding, such as an antigen-antibody reaction. In order to capture or detect specific target compounds, it is necessary to introduce into the cellulose nanofibers a substance such as an antibody (protein) that specifically binds to the target compound. If it were possible to easily introduce into the cellulose nanofibers a carboxyl group-containing compound such as biotin or a protein as a substance that specifically binds to such target compounds, the convenience of the composite particles could be improved.
本発明は、以上の点に鑑み、一実施形態において、カルボキシ基含有化合物を導入することができるセルロースナノファイバーと磁性体粒子との複合粒子及びその製造方法を提供することを目的とする。また、他の実施形態において、セルロースナノファイバーと磁性体粒子との複合粒子にカルボキシ基含有化合物が導入された新規な複合粒子及びその製造方法、並びにその利用方法を提供することを目的とする。 In view of the above, in one embodiment, the present invention aims to provide composite particles of cellulose nanofibers and magnetic particles into which a carboxy group-containing compound can be introduced, and a method for producing the same. In another embodiment, the present invention aims to provide novel composite particles in which a carboxy group-containing compound has been introduced into composite particles of cellulose nanofibers and magnetic particles, a method for producing the same, and a method for using the same.
本発明は以下に示される実施形態を含む。
[1] セルロースナノファイバーと磁性体粒子とを含む複合粒子であって、前記セルロースナノファイバーが下記一般式(1)で表される基を有し、
[2] 前記磁性体粒子の平均粒径が1~500nmである、[1]に記載の複合粒子。
The present invention includes the embodiments shown below.
[1] Composite particles containing cellulose nanofibers and magnetic particles, wherein the cellulose nanofibers have a group represented by the following general formula (1):
[2] The composite particles according to [1], wherein the magnetic particles have an average particle size of 1 to 500 nm.
[3] セルロースナノファイバーと磁性体粒子とを含む複合粒子であって、前記セルロースナノファイバーが有する下記一般式(1)で表される基の-NH2とカルボキシ基含有化合物のカルボキシ基とが脱水縮合した構造であるアミド結合を介して前記セルロースナノファイバーに結合した前記カルボキシ基含有化合物を含み、
[4] 前記カルボキシ基含有化合物が、ビオチン又はタンパク質である、[3]に記載の複合粒子。
[5] 前記ビオチン又は前記タンパク質と特異的に結合する対象化合物を捕集又は検出するために用いられる、[4]に記載の複合粒子。
[3] Composite particles containing cellulose nanofibers and magnetic particles, the particles containing a carboxy group-containing compound bound to the cellulose nanofibers via an amide bond, which is a structure formed by dehydration condensation between -NH2 of a group represented by the following general formula (1) possessed by the cellulose nanofibers and a carboxy group of the carboxy group-containing compound:
[4] The composite particle according to [3], wherein the carboxy group-containing compound is biotin or a protein.
[5] The composite particle according to [4], which is used for capturing or detecting a target compound that specifically binds to the biotin or the protein.
[6] [1]又は[2]に記載の複合粒子の製造方法であって、
カルボキシ基を有するセルロースナノファイバーと磁性体粒子とを含む複合粒子と、
ヒドラジン又は脂肪族ジアミンと、
カルボジイミド系縮合剤、イミダゾール系縮合剤、トリアジン系縮合剤、ホスホニウム系縮合剤、ウロニウム系縮合剤、及びハロウロニウム系縮合剤からなる群から選択される少なくとも1種の縮合剤と、
を有機溶媒中で混合することを含む、複合粒子の製造方法。
[6] A method for producing the composite particles according to [1] or [2],
Composite particles containing cellulose nanofibers having carboxy groups and magnetic particles;
hydrazine or an aliphatic diamine,
at least one condensing agent selected from the group consisting of carbodiimide-based condensing agents, imidazole-based condensing agents, triazine-based condensing agents, phosphonium-based condensing agents, uronium-based condensing agents, and haluronium-based condensing agents;
in an organic solvent.
[7] [1]又は[2]に記載の複合粒子に含まれる前記一般式(1)で表される基の-NH2にカルボキシ基含有化合物のカルボキシ基を反応させることを含む、カルボキシ基含有化合物が導入された複合粒子の製造方法。
[8] 前記カルボキシ基含有化合物がビオチン又はタンパク質である、[7]に記載の複合粒子の製造方法。
[7] A method for producing composite particles having a carboxy group-containing compound introduced therein, comprising reacting the carboxy group of a carboxy group-containing compound with —NH 2 of the group represented by the general formula (1) contained in the composite particles according to [1] or [2].
[8] The method for producing composite particles according to [7], wherein the carboxy group-containing compound is biotin or a protein.
[9] [4]に記載の複合粒子と、前記ビオチン又は前記タンパク質と特異的に結合する対象化合物とを、液体中で混合して、前記ビオチン又は前記タンパク質と前記対象化合物とを結合させることを含む、前記対象化合物の捕集又は検出方法。 [9] A method for capturing or detecting a target compound, comprising mixing the composite particle described in [4] with a target compound that specifically binds to the biotin or the protein in a liquid, thereby binding the biotin or the protein to the target compound.
上記実施形態であると、セルロースナノファイバーと磁性体粒子とを含む複合粒子に対し、セルロースナノファイバーに導入されたアミノ基を用いて、カルボキシ基含有化合物を導入することができる。また、カルボキシ基含有化合物が導入された新規な複合粒子を提供することができ、それを用いて、例えば特定の対象化合物を捕集又は検出するために用いることができる。 In the above embodiment, a carboxy group-containing compound can be introduced into composite particles containing cellulose nanofibers and magnetic particles using the amino groups introduced into the cellulose nanofibers. Furthermore, novel composite particles into which a carboxy group-containing compound has been introduced can be provided, which can be used, for example, to capture or detect specific target compounds.
一実施形態に係る複合粒子(A)は、アミノ基で修飾されたセルロースナノファイバーと磁性体粒子とを含む。該複合粒子(A)は、セルロースナノファイバーからなるセルロース粒子に磁性体粒子を複合化したものである。磁性体粒子は、セルロースナノファイバーに分散した状態に複合一体化されており、セルロースナノファイバーからなるセルロース粒子の粒子表面に付着していてもよく、内部に埋設されていてもよい。 Composite particles (A) according to one embodiment contain cellulose nanofibers modified with amino groups and magnetic particles. The composite particles (A) are cellulose particles made of cellulose nanofibers combined with magnetic particles. The magnetic particles are integrated into a composite in a dispersed state with the cellulose nanofibers, and may be attached to the particle surface of the cellulose particles made of cellulose nanofibers or embedded inside.
磁性体粒子としては、磁石により吸引されることが可能な強磁性体からなる粒子であれば特に限定されず、例えば、Fe3O4、γ-Fe2O3などの酸化鉄などの金属酸化物、鉄、マンガン、ニッケル、コバルト、クロムなどの金属又はこれらの合金、各種フェライトなどの金属塩、フェライト型あるいはマルテンサイト型ステンレス、アモルファス合金、シリコン鉄軟磁性結晶などの粒子が挙げられ、これらはいずれか1種又は2種以上組み合わせて用いることができる。 The magnetic particles are not particularly limited as long as they are particles made of a ferromagnetic material that can be attracted by a magnet, and examples include particles of metal oxides such as iron oxides such as Fe 3 O 4 and γ-Fe 2 O 3, metals such as iron, manganese, nickel, cobalt, and chromium, or alloys thereof, metal salts such as various ferrites, ferritic or martensitic stainless steel, amorphous alloys, and silicon-iron soft magnetic crystals, and any one of these can be used alone or in combination of two or more.
磁性体粒子の平均粒径は、特に限定されないが、1~500nmであることが好ましく、より好ましくは2~300nmであり、より好ましくは5~200nmであり、より好ましくは7~100nmであり、更に好ましくは10~50nmである。 The average particle size of the magnetic particles is not particularly limited, but is preferably 1 to 500 nm, more preferably 2 to 300 nm, more preferably 5 to 200 nm, more preferably 7 to 100 nm, and even more preferably 10 to 50 nm.
セルロースナノファイバーとしては、(a)数平均繊維径が3nm以上100nm以下であり、(b)セルロースI型結晶構造を有し、かつ、(c)平均アスペクト比が2以上5000以下であるものが好ましい。 Preferably, the cellulose nanofibers have (a) a number-average fiber diameter of 3 nm or more and 100 nm or less, (b) a cellulose type I crystal structure, and (c) an average aspect ratio of 2 or more and 5,000 or less.
上記(a)の数平均繊維径は、より好ましくは50nm以下であり、更に好ましくは30nm以下であり、10nm以下でもよい。数平均繊維径は、次のようにして測定することができる。 The number average fiber diameter of (a) above is more preferably 50 nm or less, even more preferably 30 nm or less, and may be 10 nm or less. The number average fiber diameter can be measured as follows.
すなわち、固形分率で0.05~0.1質量%のセルロースナノファイバーの水分散体を調製し、その水分散体を、親水化処理済みのカーボン膜被覆グリッド上にキャストして、透過型電子顕微鏡(TEM)の観察用試料とする。なお、大きな繊維径の繊維を含む場合には、ガラス上へキャストした表面の走査型電子顕微鏡(SEM)像を観察してもよい。また、観察用試料は、例えば2質量%ウラニルアセテートでネガティブ染色してもよい。そして、構成する繊維の大きさに応じて5000倍、10000倍あるいは50000倍のいずれかの倍率で電子顕微鏡画像による観察を行う。その際に、得られた画像内に縦横任意の画像幅の軸を想定し、その軸に対し、20本以上の繊維が交差するよう、試料および観察条件(倍率等)を調節する。そして、この条件を満たす観察画像を得た後、この画像に対し、1枚の画像当たり縦横2本ずつの無作為な軸を引き、軸に交錯する繊維の繊維径を目視で読み取っていく。このようにして、最低3枚の重複しない表面部分の画像を、電子顕微鏡で撮影し、各々2つの軸に交錯する繊維の繊維径の値を読み取る(したがって、最低20本×2×3=120本の繊維径の情報が得られる)。このようにして得られた繊維径の相加平均を数平均繊維径とする。 In other words, an aqueous dispersion of cellulose nanofibers with a solid content of 0.05 to 0.1% by mass is prepared, and this aqueous dispersion is cast onto a hydrophilically treated carbon film-coated grid to prepare a sample for observation with a transmission electron microscope (TEM). If the sample contains fibers with large diameters, a scanning electron microscope (SEM) image of the surface cast onto glass may be observed. The observation sample may also be negatively stained, for example, with 2% by mass uranyl acetate. The electron microscope image is then observed at a magnification of 5,000x, 10,000x, or 50,000x, depending on the size of the fibers. In this case, an arbitrary axis of vertical or horizontal width is assumed within the obtained image, and the sample and observation conditions (magnification, etc.) are adjusted so that 20 or more fibers intersect with this axis. After obtaining an observation image that satisfies these conditions, two random axes are drawn vertically and horizontally on the image, and the fiber diameters of the fibers intersecting the axes are visually determined. In this way, at least three non-overlapping images of the surface are taken with an electron microscope, and the fiber diameter values of the fibers intersecting each of the two axes are read (thus, information on the diameters of a minimum of 20 fibers x 2 x 3 = 120 fibers is obtained). The arithmetic mean of the fiber diameters obtained in this way is taken as the number average fiber diameter.
上記(b)のセルロースI型結晶構造を有することは、広角X線回折像測定により得られる回折プロファイルにおいて、2θ=14°~17°付近と、2θ=22°~23°付近の2つの位置に典型的なピークをもつことから同定することができる。 The presence of the cellulose type I crystal structure (b) above can be identified by the presence of two typical peaks in the diffraction profile obtained by wide-angle X-ray diffraction image measurement, around 2θ = 14° to 17° and 2θ = 22° to 23°.
上記(c)の平均アスペクト比は、より好ましくは50~1000であり、更に好ましくは100~500であり、200~400でもよい。平均アスペクト比は、次のようにして測定することができる。 The average aspect ratio of (c) above is more preferably 50 to 1000, even more preferably 100 to 500, and may be 200 to 400. The average aspect ratio can be measured as follows.
すなわち、先に述べた方法に従い数平均繊維径を算出する。また、同様の観察画像からセルロースナノファイバーの数平均繊維長を算出する。詳細には、繊維の始点から終点までの長さ(繊維長)を最低10本目視で読み取る。なお、枝分かれしている繊維については、その繊維の最も長い部分の長さを繊維長とする。このようにして得られた繊維長の相加平均を算出し、数平均繊維長とする。これらの値を用いて平均アスペクト比を下記式に従い算出する。
平均アスペクト比=数平均繊維長(nm)/数平均繊維径(nm)
That is, the number-average fiber diameter is calculated according to the method described above. The number-average fiber length of the cellulose nanofibers is also calculated from the same observation image. Specifically, the length from the start point to the end point of at least 10 fibers (fiber length) is visually read. For branched fibers, the fiber length is defined as the length of the longest part of the fiber. The arithmetic mean of the fiber lengths thus obtained is calculated, and this is defined as the number-average fiber length. Using these values, the average aspect ratio is calculated according to the following formula:
Average aspect ratio = number average fiber length (nm) / number average fiber diameter (nm)
アミノ基で修飾されたセルロースナノファイバーは、下記一般式(1)で表される基(以下、「官能基(1)」という。)を有するセルロースナノファイバーである。
式(1)中のR1は、単結合又は炭素数1~10の二価の脂肪族基を表す。該二価の脂肪族基は、飽和脂肪族基でもよく、不飽和脂肪族基でもよいが、好ましくは飽和脂肪族基(すなわち、アルカンジイル基)である。アルカンジイル基は、直鎖状でも、分岐を有してもよいが、好ましくは直鎖状である。二価の脂肪族基の炭素数は、より好ましくは2~8であり、更に好ましくは2~6である。 R 1 in formula (1) represents a single bond or a divalent aliphatic group having 1 to 10 carbon atoms. The divalent aliphatic group may be a saturated aliphatic group or an unsaturated aliphatic group, but is preferably a saturated aliphatic group (i.e., an alkanediyl group). The alkanediyl group may be linear or branched, but is preferably linear. The number of carbon atoms in the divalent aliphatic group is more preferably 2 to 8, and even more preferably 2 to 6.
一実施形態において、アミノ基で修飾されたセルロースナノファイバーは、カルボキシ基含有セルロースナノファイバーのカルボキシ基にヒドラジン又は脂肪族ジアミンのアミノ基を脱水縮合反応させることにより得られる。 In one embodiment, cellulose nanofibers modified with amino groups are obtained by subjecting the carboxy groups of carboxy group-containing cellulose nanofibers to a dehydration condensation reaction with the amino groups of hydrazine or an aliphatic diamine.
カルボキシ基含有セルロースナノファイバーは、カルボキシ基を有するセルロースナノファイバーであり、例えば、セルロース分子中のグルコースユニットの水酸基を酸化してなる酸化セルロースナノファイバーや、セルロース分子中のグルコースユニットの水酸基をカルボキシメチル化してなるカルボキシメチル化セルロースナノファイバーが挙げられる。 Carboxy group-containing cellulose nanofibers are cellulose nanofibers that have carboxy groups, and examples include oxidized cellulose nanofibers formed by oxidizing the hydroxyl groups of the glucose units in cellulose molecules, and carboxymethylated cellulose nanofibers formed by carboxymethylating the hydroxyl groups of the glucose units in cellulose molecules.
酸化セルロースナノファイバーとしては、セルロース分子中のグルコースユニットのC6位の水酸基が選択的に酸化されてカルボキシ基に変性されたものが挙げられる。該酸化セルロースナノファイバーは、木材パルプなどの天然セルロースをN-オキシル化合物の存在下、共酸化剤を用いて酸化させ、解繊(微細化)処理することにより得られる。N-オキシル化合物としては、一般に酸化触媒として用いられるニトロキシラジカルを有する化合物が用いられ、例えばピペリジンニトロキシオキシラジカルであり、特に2,2,6,6-テトラメチルピペリジノオキシラジカル(TEMPO)又は4-アセトアミド-TEMPOが好ましい。TEMPOで酸化されたセルロースナノファイバーは、一般にTEMPO酸化セルロースナノファイバー(TOCN)と称されている。なお、酸化セルロースナノファイバーは、カルボキシ基とともに、アルデヒド基又はケトン基を有していてもよい。 Oxidized cellulose nanofibers include those in which the hydroxyl group at the C6 position of the glucose unit in the cellulose molecule has been selectively oxidized to a carboxyl group. These oxidized cellulose nanofibers are obtained by oxidizing natural cellulose, such as wood pulp, using a co-oxidant in the presence of an N-oxyl compound and then defibrating (refining) it. The N-oxyl compound used is a compound containing a nitroxy radical, which is commonly used as an oxidation catalyst. For example, a piperidine nitroxyoxy radical is used. 2,2,6,6-tetramethylpiperidinoxy radical (TEMPO) or 4-acetamido-TEMPO is particularly preferred. Cellulose nanofibers oxidized with TEMPO are generally referred to as TEMPO-oxidized cellulose nanofibers (TOCN). Oxidized cellulose nanofibers may also contain aldehyde or ketone groups in addition to the carboxyl groups.
カルボキシ基含有セルロースナノファイバーは、解繊処理を行うことにより得てもよい。解繊処理は、カルボキシ基を導入してから実施してもよく、導入前に実施してもよい。解繊処理は、例えば、高速回転下でのホモミキサー、高圧ホモジナイザー、超音波分散処理機、ビーター、ディスク型レファイナー、コニカル型レファイナー、ダブルディスク型レファイナー、グラインダー等を用いて、セルロース繊維の分散液を処理することにより行うことができ、セルロースナノファイバーの分散液を得ることができる。 Carboxy group-containing cellulose nanofibers may be obtained by defibration treatment. The defibration treatment may be carried out after or before the introduction of carboxy groups. The defibration treatment can be carried out by processing a dispersion of cellulose fibers using, for example, a homomixer, high-pressure homogenizer, ultrasonic dispersion processor, beater, disk refiner, conical refiner, double-disc refiner, grinder, etc. at high speed, and a dispersion of cellulose nanofibers can be obtained.
カルボキシ基含有セルロースナノファイバーにおけるカルボキシ基の量は、特に限定されず、例えば、カルボキシ基含有セルロースナノファイバーの乾燥質量あたり、0.5~3.0mmol/gでもよく、1.5~2.0mmol/gでもよい。カルボキシ基の量は、0.1~1質量%の濃度に調製したセルロースナノファイバー含有スラリーを60mL調製し、0.1mol/Lの塩酸水溶液によってpHを約2.5とした後、0.05mol/Lの水酸化ナトリウム水溶液を滴下して、電気伝導度測定を行い、pHが約11になるまで続け、電気伝導度の変化が緩やかな弱酸の中和段階において消費された水酸化ナトリウム量(V)から、下記式に従い求めることができる。
カルボキシ基量(mmol/g)=V(mL)×〔0.05/セルロースナノファイバー質量(g)〕
The amount of carboxy groups in the carboxy group-containing cellulose nanofibers is not particularly limited, and may be, for example, 0.5 to 3.0 mmol/g or 1.5 to 2.0 mmol/g per dry mass of the carboxy group-containing cellulose nanofibers. The amount of carboxy groups can be determined according to the following formula: 60 mL of a cellulose nanofiber-containing slurry adjusted to a concentration of 0.1 to 1 mass % is prepared, the pH is adjusted to about 2.5 with a 0.1 mol/L aqueous hydrochloric acid solution, a 0.05 mol/L aqueous sodium hydroxide solution is added dropwise, and electrical conductivity is measured, continuing until the pH reaches about 11, and the amount of sodium hydroxide (V) consumed in the neutralization stage of the weak acid, where the change in electrical conductivity is gradual, is used.
Amount of carboxyl group (mmol/g) = V (mL) × [0.05/mass of cellulose nanofiber (g)]
カルボキシ基含有セルロースナノファイバーに反応させる脂肪族ジアミンとしては、炭素数1~10の脂肪族ジアミンが用いられ、これによりセルロースナノファイバーに官能基(1)が導入される。脂肪族ジアミンの炭素数は、2~8であることが好ましく、より好ましくは2~6である。 Aliphatic diamines with 1 to 10 carbon atoms are used as the aliphatic diamines to be reacted with the carboxyl group-containing cellulose nanofibers, thereby introducing functional group (1) into the cellulose nanofibers. The aliphatic diamine preferably has 2 to 8 carbon atoms, and more preferably 2 to 6 carbon atoms.
脂肪族ジアミンとしては、飽和脂肪族ジアミンが好ましく、より好ましくはアルキレンジアミンであり、更に好ましくは直鎖アルキレンジアミンである。アルキレンジアミンの具体例としては、エチレンジアミン、プロピレンジアミン、トリメチレンジアミン、テトラメチレンジアミン、ペンタメチレンジアミン、ヘキサメチレンジアミン等が挙げられ、これらはいずれか1種用いてもよく、2種以上併用してもよい。 As the aliphatic diamine, saturated aliphatic diamines are preferred, alkylenediamines are more preferred, and straight-chain alkylenediamines are even more preferred. Specific examples of alkylenediamines include ethylenediamine, propylenediamine, trimethylenediamine, tetramethylenediamine, pentamethylenediamine, and hexamethylenediamine, and any of these may be used alone or in combination of two or more.
官能基(1)は、カルボキシ基含有セルロースナノファイバーの全てのカルボキシ基に対して導入されてもよく、一部のカルボキシ基に対して導入されてもよい。例えば、複合粒子(A)の少なくとも粒子表面のカルボキシ基に対して官能基(1)が導入されることが好ましい。なお、官能基(1)の量は、特に限定されず、例えば、上記のカルボキシ基の量と同様、官能基(1)を有するセルロースナノファイバーの乾燥質量あたり、0.5~3.0mmol/gでもよく、1.5~2.0mmol/gでもよい。 Functional group (1) may be introduced to all or some of the carboxy groups of the carboxy group-containing cellulose nanofibers. For example, it is preferable that functional group (1) be introduced to at least the carboxy groups on the particle surface of composite particle (A). The amount of functional group (1) is not particularly limited, and may be, for example, 0.5 to 3.0 mmol/g or 1.5 to 2.0 mmol/g per dry mass of cellulose nanofibers having functional group (1), similar to the amount of carboxy groups described above.
複合粒子(A)において、官能基(1)を有するセルロースナノファイバーと磁性体粒子との比率は、特に限定されず、セルロースナノファイバー(C)に対する磁性体粒子(M)の質量比M/Cで0.01~10でもよく、0.05~2でもよく、0.08~1でもよく、0.1~0.5でもよい。 In the composite particles (A), the ratio of cellulose nanofibers having functional groups (1) to magnetic particles is not particularly limited, and the mass ratio M/C of magnetic particles (M) to cellulose nanofibers (C) may be 0.01 to 10, 0.05 to 2, 0.08 to 1, or 0.1 to 0.5.
複合粒子(A)は、取り扱い性の観点からマイクロサイズであることが好ましい。より詳細には、該複合粒子の平均粒径は、1~30μmでもよく、1~20μmでもよく、2~15μmでもよい。 The composite particles (A) are preferably micro-sized from the standpoint of ease of handling. More specifically, the average particle size of the composite particles may be 1 to 30 μm, 1 to 20 μm, or 2 to 15 μm.
複合粒子(A)は、セルロースナノファイバーと磁性体粒子により形成されるものであり、セルロースナノファイバーと磁性体粒子のみで構成されてもよいが、その他の成分を含有してもよい。 The composite particles (A) are formed from cellulose nanofibers and magnetic particles, and may consist solely of cellulose nanofibers and magnetic particles, but may also contain other components.
複合粒子(A)の製造方法は、特に限定されない。例えば、カルボキシ基含有セルロースナノファイバーと磁性体粒子を含む分散液を噴霧乾燥すること(工程1)、及び、噴霧乾燥により得られた複合粒子に含まれるセルロースナノファイバーのカルボキシ基にヒドラジン又は脂肪族ジアミンを反応させること(工程2)、を含む方法により製造することができる。 There are no particular restrictions on the method for producing the composite particles (A). For example, they can be produced by a method comprising spray-drying a dispersion containing carboxyl group-containing cellulose nanofibers and magnetic particles (Step 1), and reacting the carboxyl groups of the cellulose nanofibers contained in the composite particles obtained by spray-drying with hydrazine or an aliphatic diamine (Step 2).
工程1において、分散液を噴霧乾燥することにより、セルロースナノファイバーを凝集させることなく乾燥粉体を得ることができ、セルロースナノファイバーと磁性体粒子を複合化することができる。噴霧乾燥に用いる分散液は、例えば溶媒として水を用いて、当該溶媒にセルロースナノファイバーと磁性体粒子を均一に混合分散させることにより調製される。分散液におけるセルロースナノファイバーの濃度は、噴霧乾燥によりセルロース粒子を形成することができれば特に限定されず、例えば、0.005~5質量%でもよく、0.01~1質量%でもよい。磁性体粒子の濃度も特に限定されず、例えば、0.005~5質量%でもよく、0.01~1質量%でもよい。 In step 1, spray drying the dispersion liquid allows for the production of a dry powder without agglomerating the cellulose nanofibers, thereby enabling the cellulose nanofibers and magnetic particles to be composited. The dispersion liquid used for spray drying is prepared, for example, by using water as a solvent and uniformly mixing and dispersing the cellulose nanofibers and magnetic particles in the solvent. The concentration of cellulose nanofibers in the dispersion liquid is not particularly limited as long as cellulose particles can be formed by spray drying, and may be, for example, 0.005 to 5% by mass or 0.01 to 1% by mass. The concentration of magnetic particles is also not particularly limited, and may be, for example, 0.005 to 5% by mass or 0.01 to 1% by mass.
分散液におけるセルロースナノファイバーと磁性体粒子との比率は、複合粒子(A)での比率と同様、セルロースナノファイバー(C)に対する磁性体粒子(M)の質量比M/Cで0.01~10でもよく、0.05~2でもよく、0.08~1でもよく、0.1~0.5でもよい。 The ratio of cellulose nanofibers to magnetic particles in the dispersion, similar to the ratio in the composite particles (A), may be 0.01 to 10, 0.05 to 2, 0.08 to 1, or 0.1 to 0.5, in terms of the mass ratio M/C of magnetic particles (M) to cellulose nanofibers (C).
噴霧乾燥は、分散液を気体中に噴霧して急速に乾燥させることで、乾燥粉体を作製する方法であり、公知の噴霧乾燥機を用いて行うことができる。噴霧乾燥における乾燥温度は、特に限定されず、例えば150~200℃でもよい。 Spray drying is a method of producing dry powder by spraying a dispersion into a gas and rapidly drying it, and can be carried out using a known spray dryer. There are no particular restrictions on the drying temperature in spray drying, and it can be, for example, 150 to 200°C.
噴霧乾燥に用いる分散液は、カルボキシ基に反応する架橋剤を含んでもよい。架橋剤を含むことにより、噴霧乾燥する工程でセルロースナノファイバーのカルボキシ基と架橋剤とが反応し、架橋構造を有する複合粒子を得ることができる。これにより、複合粒子を水等の液体に再分散させた際の複合粒子の形状保持効果に優れ、耐久性を高めることができる。架橋剤としては、特に限定されず、例えば、アミノ樹脂、エポキシ化合物、アジリジン化合物、カルボジイミド化合物、オキサゾリン化合物、ポリイソシアネート化合物等が挙げられる。 The dispersion liquid used for spray drying may contain a crosslinking agent that reacts with carboxy groups. By including a crosslinking agent, the carboxy groups of the cellulose nanofibers react with the crosslinking agent during the spray drying process, resulting in composite particles with a crosslinked structure. This allows the composite particles to retain their shape well when redispersed in a liquid such as water, improving durability. The crosslinking agent is not particularly limited, and examples include amino resins, epoxy compounds, aziridine compounds, carbodiimide compounds, oxazoline compounds, polyisocyanate compounds, etc.
工程2において、ヒドラジン又は脂肪族ジアミンを反応させる方法は、カルボキシ基含有セルロースナノファイバーのカルボキシ基とヒドラジン又は脂肪族ジアミンのアミノ基とが脱水縮合によりアミド結合を形成することができれば、特に限定されない。一実施形態において、上記噴霧乾燥により得られた複合粒子と、ヒドラジン又は脂肪族ジアミンと、縮合剤と、を有機溶媒中で混合する工程(工程2a)を含むことが好ましい。これにより、粒子表面のカルボキシ基に対してより効率的に官能基(1)を導入することができる。 In step 2, the method for reacting hydrazine or aliphatic diamine is not particularly limited, as long as it allows the carboxy groups of the carboxy group-containing cellulose nanofibers and the amino groups of the hydrazine or aliphatic diamine to form amide bonds through dehydration condensation. In one embodiment, it is preferable to include a step (step 2a) of mixing the composite particles obtained by the above-mentioned spray drying with hydrazine or aliphatic diamine and a condensing agent in an organic solvent. This allows functional group (1) to be introduced more efficiently into the carboxy groups on the particle surface.
工程2aにおいて、縮合剤としては、カルボジイミド系縮合剤、イミダゾール系縮合剤、トリアジン系縮合剤、ホスホニウム系縮合剤、ウロニウム系縮合剤、及びハロウロニウム系縮合剤からなる群から選択される少なくとも1種が挙げられる。 In step 2a, the condensing agent may be at least one selected from the group consisting of carbodiimide condensing agents, imidazole condensing agents, triazine condensing agents, phosphonium condensing agents, uronium condensing agents, and haluronium condensing agents.
カルボジイミド系縮合剤としては、例えば、1-[3-(ジメチルアミノ)プロピル]-3-エチルカルボジイミド、塩酸1-エチル-3-(3-ジメチルアミノプロピル)カルボジイミド、N,N’-ジシクロヘキシルカルボジイミド、N,N’-ジイソプロピルカルボジイミドなどが挙げられる。 Examples of carbodiimide condensing agents include 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride, N,N'-dicyclohexylcarbodiimide, and N,N'-diisopropylcarbodiimide.
イミダゾール系縮合剤としては、例えば、N,N’-カルボニルジイミダゾール、1,1’-カルボニルジ(1,2,4-トリアゾール)などが挙げられる。 Examples of imidazole-based condensing agents include N,N'-carbonyldiimidazole and 1,1'-carbonyldi(1,2,4-triazole).
トリアジン系縮合剤としては、例えば、4-(4,6-ジメトキシ-1,3,5-トリアジン-2-イル)-4-メチルモルホリニウム=クロリドn水和物、トリフルオロメタンスルホン酸(4,6-ジメトキシ-1,3,5-トリアジン-2-イル)-(2-オクトキシ-2-オキソエチル)ジメチルアンモニウムなどが挙げられる。 Examples of triazine-based condensing agents include 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride n-hydrate and (4,6-dimethoxy-1,3,5-triazin-2-yl)-(2-octoxy-2-oxoethyl)dimethylammonium trifluoromethanesulfonate.
ホスホニウム系縮合剤としては、例えば、1H-ベンゾトリアゾール-1-イルオキシトリス(ジメチルアミノ)ホスホニウムヘキサフルオロりん酸塩、1H-ベンゾトリアゾール-1-イルオキシトリピロリジノホスホニウムヘキサフルオロりん酸塩、(7-アザベンゾトリアゾール-1-イルオキシ)トリピロリジノホスホニウムヘキサフルオロりん酸塩、クロロトリピロリジノホスホニウムヘキサフルオロりん酸塩、ブロモトリス(ジメチルアミノ)ホスホニウムヘキサフルオロりん酸塩、3-(ジエトキシホスホリルオキシ)-1,2,3-ベンゾトリアジン-4(3H)-オンなどが挙げられる。 Examples of phosphonium condensing agents include 1H-benzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluorophosphate, 1H-benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate, (7-azabenzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate, chlorotripyrrolidinophosphonium hexafluorophosphate, bromotris(dimethylamino)phosphonium hexafluorophosphate, and 3-(diethoxyphosphoryloxy)-1,2,3-benzotriazin-4(3H)-one.
ウロニウム系縮合剤としては、例えば、O-(ベンゾトリアゾール-1-イル)-N,N,N’,N’-テトラメチルウロニウムヘキサフルオロりん酸塩、O-(7-アザベンゾトリアゾール-1-イル)-N,N,N’,N’-テトラメチルウロニウムヘキサフルオロりん酸塩、O-(N-スクシンイミジル)-N,N,N’,N’-テトラメチルウロニウムテトラフルオロほう酸塩、O-(N-スクシンイミジル)-N,N,N’,N’-テトラメチルウロニウムヘキサフルオロりん酸塩、O-(3,4-ジヒドロ-4-オキソ-1,2,3-ベンゾトリアジン-3-イル)-N,N,N’,N’-テトラメチルウロニウムテトラフルオロほう酸塩、S-(1-オキシド-2-ピリジル)-N,N,N’,N’-テトラメチルチウロニウムテトラフルオロほう酸塩、O-[2-オキソ-1(2H)-ピリジル]-N,N,N’,N’-テトラメチルウロニウムテトラフルオロほう酸塩、{{[(1-シアノ-2-エトキシ-2-オキソエチリデン)アミノ]オキシ}-4-モルホリノメチレン}ジメチルアンモニウムヘキサフルオロりん酸塩などが挙げられる。 Examples of uronium-based condensing agents include O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate, O-(7-azabenzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate, O-(N-succinimidyl)-N,N,N',N'-tetramethyluronium tetrafluoroborate, O-(N-succinimidyl)-N,N,N',N'-tetramethyluronium hexafluorophosphate, O-(3,4-dihydro-4-oxo -1,2,3-benzotriazin-3-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate, S-(1-oxido-2-pyridyl)-N,N,N',N'-tetramethylthiuronium tetrafluoroborate, O-[2-oxo-1(2H)-pyridyl]-N,N,N',N'-tetramethyluronium tetrafluoroborate, {{[(1-cyano-2-ethoxy-2-oxoethylidene)amino]oxy}-4-morpholinomethylene}dimethylammonium hexafluorophosphate, etc.
ハロウロニウム系縮合剤としては、例えば、2-クロロ-1,3-ジメチルイミダゾリニウムヘキサフルオロりん酸塩、1-(クロロ-1-ピロリジニルメチレン)ピロリジニウムヘキサフルオロりん酸塩、2-フルオロ-1,3-ジメチルイミダゾリニウムヘキサフルオロりん酸塩、フルオロ-N,N,N’,N’-テトラメチルホルムアミジニウムヘキサフルオロりん酸塩などが挙げられる。 Examples of halouronium condensing agents include 2-chloro-1,3-dimethylimidazolinium hexafluorophosphate, 1-(chloro-1-pyrrolidinylmethylene)pyrrolidinium hexafluorophosphate, 2-fluoro-1,3-dimethylimidazolinium hexafluorophosphate, and fluoro-N,N,N',N'-tetramethylformamidinium hexafluorophosphate.
これらの縮合剤は、いずか1種用いても2種以上併用してもよい。 These condensing agents may be used alone or in combination of two or more.
工程2aにおいて、有機溶媒としては、特に限定されず、例えばジメチルホルムアミド、ジメチルスルホキシド、テトラヒドロフラン、ジクロロメタン、アセトン、クロロホルム、トルエン、1,2-ジクロロエタン、1,4-ジオキサン、酢酸エチルなどが挙げられる。 In step 2a, the organic solvent is not particularly limited, but examples include dimethylformamide, dimethyl sulfoxide, tetrahydrofuran, dichloromethane, acetone, chloroform, toluene, 1,2-dichloroethane, 1,4-dioxane, and ethyl acetate.
工程2及び工程2aにおいて、ヒドラジン又は脂肪族ジアミンの量は特に限定されず、例えば、複合粒子を構成するセルロースナノファイバーのカルボキシ基の量に対して等モル以上を加えてもよい。縮合剤の量も特に限定されず、例えば、複合粒子を構成するセルロースナノファイバーのカルボキシ基の量に対して等モル以上を加えてもよい。 In steps 2 and 2a, the amount of hydrazine or aliphatic diamine is not particularly limited, and may be added in an amount equal to or greater than the amount of carboxy groups in the cellulose nanofibers that make up the composite particles, for example. The amount of condensing agent is also not particularly limited, and may be added in an amount equal to or greater than the amount of carboxy groups in the cellulose nanofibers that make up the composite particles, for example.
一実施形態に係る複合粒子(B)は、セルロースナノファイバーと磁性体粒子とを含む複合粒子にカルボキシ基含有化合物が導入されたものである。詳細には、複合粒子(B)は、上記複合粒子(A)に導入された官能基(1)の-NH2とカルボキシ基含有化合物のカルボキシ基とが脱水縮合した構造であるアミド結合を介してセルロースナノファイバーに結合したカルボキシ基含有化合物を含む。 The composite particle (B) according to one embodiment is a composite particle containing cellulose nanofibers and magnetic particles, to which a carboxy group-containing compound has been introduced. Specifically, the composite particle (B) contains a carboxy group-containing compound bound to the cellulose nanofibers via an amide bond, which is a structure formed by dehydration condensation between the -NH2 of the functional group (1) introduced into the composite particle (A) and the carboxy group of the carboxy group-containing compound.
上記複合粒子(A)は一級アミノ基(-NH2)を持つため、タンパク質等のカルボキシ基含有化合物と反応してアミド結合を形成することができる。これにより、カルボキシ基含有化合物が導入された複合粒子(B)を容易に得ることができる。そのため、上記複合粒子(A)は、タンパク質等のカルボキシ基含有化合物を結合させる前駆体として好適に用いられる。 Since the composite particles (A) have a primary amino group (—NH 2 ), they can react with a carboxyl group-containing compound such as a protein to form an amide bond. This makes it possible to easily obtain composite particles (B) into which a carboxyl group-containing compound has been introduced. Therefore, the composite particles (A) are suitable for use as precursors for bonding a carboxyl group-containing compound such as a protein.
カルボキシ基含有化合物としては、例えば、ビオチン又はタンパク質が好ましい。タンパク質としては、抗体、ペプチド、プロテインA、プロテインG、プロテインL、ストレプトアビジン、酵素などが挙げられる。 Preferred examples of carboxyl group-containing compounds include biotin and proteins. Examples of proteins include antibodies, peptides, protein A, protein G, protein L, streptavidin, and enzymes.
これらのカルボキシ基含有化合物は、そのカルボキシ基が活性エステル化されたものでもよく、カルボキシ基含有化合物のカルボキシ基には、当該活性エステル化された活性エステル基もその概念に包含される。活性エステル化する方法は特に限定されず、例えば、N-ヒドロキシスクシンイミド、炭酸N,N’-ジスクシンイミジル、N-ヒドロキシスルホスクシンイミドアルカリ金属塩、1-ヒドロキシベンゾトリアゾール、1-ヒドロキシ-7-アザベンゾトリアゾール、エチル(ヒドロキシイミノ)シアノアセタート、ペンタフルオロフェノール、ニトロフェノールなどの添加剤を、上記縮合剤を用いて、カルボキシ基含有化合物と反応させる方法が挙げられる。 These carboxy group-containing compounds may have their carboxy groups converted into active esters, and the concept of the carboxy group of a carboxy group-containing compound encompasses such active esterified active ester groups. The method for converting into an active ester is not particularly limited, and examples include a method in which an additive such as N-hydroxysuccinimide, N,N'-disuccinimidyl carbonate, N-hydroxysulfosuccinimide alkali metal salt, 1-hydroxybenzotriazole, 1-hydroxy-7-azabenzotriazole, ethyl (hydroxyimino)cyanoacetate, pentafluorophenol, or nitrophenol is reacted with the carboxy group-containing compound using the condensing agent described above.
複合粒子(A)に含まれる官能基(1)の一級アミノ基にカルボキシ基含有化合物のカルボキシ基を反応させる方法は、特に限定されない。 There are no particular limitations on the method for reacting the primary amino group of the functional group (1) contained in the composite particle (A) with the carboxy group of the carboxy group-containing compound.
例えば、カルボキシ基含有化合物のカルボキシ基が活性エステル化されていない場合、複合粒子(A)と、カルボキシ基含有化合物と、上記縮合剤とを有機溶媒中で混合することにより、複合粒子(A)にカルボキシ基含有化合物が導入されて複合粒子(B)が得られる。カルボキシ基含有化合物のカルボキシ基が活性エステル化されている場合、複合粒子(A)と、活性エステル化されたカルボキシ基含有化合物とを有機溶媒中で混合することにより、複合粒子(A)にカルボキシ基含有化合物が導入されて複合粒子(B)が得られる。これらの場合に用いる有機溶媒としては、特に限定されず、例えばジメチルホルムアミド、メチルスルホキシド、テトラヒドロフラン、ジクロロメタン、アセトン、クロロホルム、トルエン、1,2-ジクロロエタン、1,4-ジオキサン、酢酸エチルなどが挙げられる。また、カルボキシ基含有化合物の使用量は特に限定されず、例えば複合粒子を構成するセルロースナノファイバーの一級アミノ基の量に対して等モル以上を加えてもよい。 For example, if the carboxy group of the carboxy group-containing compound is not actively esterified, the carboxy group-containing compound is introduced into the composite particle (A) by mixing the composite particle (A), the carboxy group-containing compound, and the condensing agent in an organic solvent, thereby obtaining composite particle (B). If the carboxy group of the carboxy group-containing compound is actively esterified, the carboxy group-containing compound is introduced into the composite particle (A) by mixing the composite particle (A) with the actively esterified carboxy group-containing compound in an organic solvent, thereby obtaining composite particle (B). The organic solvent used in these cases is not particularly limited, and examples include dimethylformamide, methyl sulfoxide, tetrahydrofuran, dichloromethane, acetone, chloroform, toluene, 1,2-dichloroethane, 1,4-dioxane, and ethyl acetate. The amount of the carboxy group-containing compound used is also not particularly limited, and may be added in an amount equal to or greater than the amount of primary amino groups in the cellulose nanofibers that make up the composite particle.
このようにしてビオチン又はタンパク質が導入された複合粒子(B)は、ビオチン又はタンパク質と特異的に結合する対象化合物を捕集又は検出するために好適に用いられる。対象化合物としては、例えば、ビオチンが導入された複合粒子(B)の場合、ビオチンと特異的に結合するアビジン、ストレプトアビジンなどが挙げられる。例えば、タンパク質として抗体が導入された複合粒子(B)の場合、対象化合物は、当該抗体と特異的に結合する抗原である。このようにアビジン-ビオチン相互作用や、抗原抗体反応などを利用して、特定の対象化合物の捕集又は検出を行うことができる。 Composite particles (B) with biotin or protein introduced in this manner are suitable for use in capturing or detecting target compounds that specifically bind to biotin or protein. For example, in the case of composite particles (B) with biotin introduced, examples of the target compound include avidin and streptavidin, which specifically bind to biotin. For example, in the case of composite particles (B) with an antibody introduced as the protein, the target compound is an antigen that specifically binds to the antibody. In this way, specific target compounds can be captured or detected by utilizing avidin-biotin interactions or antigen-antibody reactions.
一実施形態に係る対象化合物の捕集又は検出方法は、ビオチン又はタンパク質が導入された複合粒子(B)と、これらと特異的に結合する対象化合物とを、液体中で混合して、ビオチン又はタンパク質と対象化合物とを結合させることを含む。より詳細には、例えば、対象化合物を含むか又は含むことが疑われる液体中に上記複合粒子(B)を添加して混合する。これにより、対象化合物と複合粒子(B)のビオチン又はタンパク質とを特異的に結合させることができる。その後、複合粒子(B)が分散した液体から磁石を用いた磁気分離により、対象化合物が結合した複合粒子(B)を上記液体から収集(回収)することができる。 In one embodiment, a method for capturing or detecting a target compound involves mixing composite particles (B) into which biotin or protein has been introduced with a target compound that specifically binds to these particles in a liquid, thereby binding the biotin or protein to the target compound. More specifically, for example, the composite particles (B) are added to and mixed with a liquid that contains or is suspected of containing the target compound. This allows the target compound to specifically bind to the biotin or protein of the composite particles (B). The composite particles (B) to which the target compound has bound can then be collected (recovered) from the liquid in which the composite particles (B) are dispersed by magnetic separation using a magnet.
磁気分離による複合粒子(B)の収集に際しては、例えば、液体に複合粒子(B)が分散しているとき、磁石を用いることで、その磁力により複合粒子(B)を容器の壁面に引きつけて集めることができるので、容易に液体から分離することができる。なお、磁石としては、永久磁石でもよく、電磁石でもよい。このような磁気分離による複合粒子の収集は様々な場面で用いることができる。例えば、上記複合粒子(A)の製造方法におけるアミド化反応前の複合粒子の洗浄時、アミド化反応後の反応溶液からの複合粒子(A)の分離及び洗浄時、カルボキシ基含有化合物の導入工程における導入反応後の反応溶液からの複合粒子(B)の分離及び洗浄時、並びに、対象化合物の捕集又は検出方法において対象化合物を結合させた後の液体からの複合粒子(B)の分離及び洗浄時などが挙げられる。 When collecting composite particles (B) by magnetic separation, for example, when composite particles (B) are dispersed in a liquid, a magnet can be used to attract and collect the composite particles (B) to the wall of a container using its magnetic force, allowing them to be easily separated from the liquid. The magnet may be a permanent magnet or an electromagnet. Such collection of composite particles by magnetic separation can be used in a variety of situations. Examples include when washing composite particles before the amidation reaction in the method for producing composite particles (A), when separating and washing composite particles (A) from the reaction solution after the amidation reaction, when separating and washing composite particles (B) from the reaction solution after the introduction reaction in the step of introducing a carboxy group-containing compound, and when separating and washing composite particles (B) from the liquid after binding to the target compound in a method for capturing or detecting the target compound.
本実施形態に係る複合粒子は、例えば、サンドイッチELISAに用いてもよい。具体的には、官能基(1)を有する複合粒子(A)に、カルボキシ基含有化合物として抗体(捕捉用抗体)を反応させて捕捉用抗体を導入した複合粒子(B)を作製する。次いで、該複合粒子(B)を、対象化合物としての抗原を含むか又は含むことが疑われる液体と混合して、抗原と捕捉用抗体を結合させる。その後、酵素標識抗体(検出用抗体)を加えて、捕捉用抗体と結合している抗原に検出用抗体を結合させる。その後、酵素に対する発色基質、呈色基質又は発光基質を加えて反応させて発色、呈色又は発光させ、発色、呈色又は発光の強度を測定することにより、対象化合物を定量的に検出することができる。 The composite particles according to this embodiment may be used, for example, in sandwich ELISA. Specifically, a composite particle (A) having a functional group (1) is reacted with an antibody (capture antibody) as a carboxy group-containing compound to produce a composite particle (B) incorporating the capture antibody. The composite particle (B) is then mixed with a liquid containing or suspected of containing an antigen as the target compound, causing the antigen to bind to the capture antibody. An enzyme-labeled antibody (detection antibody) is then added, causing the detection antibody to bind to the antigen bound to the capture antibody. A chromogenic substrate, colorimetric substrate, or luminescent substrate for the enzyme is then added, causing a reaction to develop color, color, or light, and the intensity of the color, color, or light emission is measured, allowing the target compound to be quantitatively detected.
本実施形態に係る複合粒子は、例えば、アビジン-ビオチン相互作用を利用してアビジンやストレプトアビジン(以下、単にアビジンという。)を検出するために用いてもよい。具体的には、官能基(1)を有する複合粒子(A)に、ビオチンを反応させてビオチンを導入した複合粒子(B)を作製する。次いで、該複合粒子(B)を、対象化合物としての酵素標識アビジンを含むか又は含むことが疑われる液体と混合して、ビオチンと酵素標識アビジンを結合させる。その後、酵素に対する発色基質、呈色基質又は発光基質を加えて反応させて発色、呈色又は発光させ、発色、呈色又は発光の強度を測定することにより、対象化合物を定量的に検出することができる。 The composite particles according to this embodiment may be used, for example, to detect avidin or streptavidin (hereinafter simply referred to as avidin) by utilizing the avidin-biotin interaction. Specifically, biotin is introduced into composite particles (A) having functional group (1) by reacting them with biotin to produce composite particles (B). Next, the composite particles (B) are mixed with a liquid containing or suspected of containing enzyme-labeled avidin as the target compound, thereby binding the biotin and enzyme-labeled avidin. A color-developing substrate, color-developing substrate, or luminescent substrate for the enzyme is then added and reacted to produce color, color, or light. The intensity of the color, color, or light emission is measured, allowing the target compound to be quantitatively detected.
以下、実施例により更に詳細に説明するが、本発明はこれらに限定されない。 The following provides a more detailed explanation using examples, but the present invention is not limited to these.
[TOCN磁性複合粒子の調製]
<測定方法>
(1)セルロースナノファイバーの数平均繊維径
セルロースナノファイバーの数平均繊維径を、透過型電子顕微鏡(TEM)(日本電子社製、JEM-1400)を用いて観察した。すなわち、試料を親水化処理済みのカーボン膜被覆グリッド上にキャストした後、2質量%ウラニルアセテート水溶液でネガティブ染色したTEM像(倍率:10000倍)から、先に述べた方法に従い、数平均繊維径を算出した。
[Preparation of TOCN Magnetic Composite Particles]
<Measurement method>
(1) Number-average fiber diameter of cellulose nanofibers The number-average fiber diameter of cellulose nanofibers was observed using a transmission electron microscope (TEM) (JEM-1400, manufactured by JEOL Ltd.). Specifically, a sample was cast onto a hydrophilically treated carbon film-coated grid, and then the number-average fiber diameter was calculated from a TEM image (magnification: 10,000x) negatively stained with a 2% by mass aqueous solution of uranyl acetate, according to the method described above.
(2)セルロースナノファイバーの平均アスペクト比
数平均繊維径の測定と同様に調製した観察用試料を用いて、先に述べた方法に従い、セルロースナノファイバーの数平均繊維長を算出した。そして、上記数平均繊維径と数平均繊維長の値を用いて平均アスペクト比を上記式に従い算出した。
(2) Average aspect ratio of cellulose nanofibers Using observation samples prepared in the same manner as for measuring the number average fiber diameter, the number average fiber length of the cellulose nanofibers was calculated according to the method described above. The average aspect ratio was then calculated according to the above formula using the number average fiber diameter and number average fiber length values.
(3)セルロースナノファイバーの結晶構造
X線回折装置(リガク社製、RINT-Ultima3)を用いて、試料の回折プロファイルを測定し、2θ=14°~17°付近と、2θ=22°~23°付近の2つの位置に典型的なピークが見られる場合は結晶構造(I型結晶構造)が「あり」と評価し、ピークが見られない場合は「なし」と評価した。
(3) Crystalline structure of cellulose nanofibers The diffraction profile of the sample was measured using an X-ray diffractometer (Rigaku Corporation, RINT-Ultima3). If typical peaks were observed at two positions, around 2θ = 14° to 17° and 2θ = 22° to 23°, the sample was evaluated as having a crystalline structure (type I crystal structure). If no peaks were observed, the sample was evaluated as having no crystalline structure.
(4)セルロースナノファイバーのカルボキシ基量
試料0.25gを水に分散させた水分散体60mLを調製し、0.1Mの塩酸水溶液によってpHを約2.5とした後、0.05Mの水酸化ナトリウム水溶液を滴下して、電気伝導度測定を行い、先に述べた方法に従い、カルボキシ基量を求めた。
(4) Amount of carboxyl groups in cellulose nanofibers 60 mL of an aqueous dispersion was prepared by dispersing 0.25 g of a sample in water, and the pH was adjusted to approximately 2.5 with 0.1 M aqueous hydrochloric acid solution. After that, 0.05 M aqueous sodium hydroxide solution was added dropwise, and electrical conductivity was measured, and the amount of carboxyl groups was determined according to the method described above.
(5)複合粒子及び磁性体粒子の平均粒径
SEM(走査型電子顕微鏡:S-5000、日立ハイテクノロジーズ社製、20kVの条件)により、倍率5千~2万倍で写真を撮影して、任意に200個以上の粒子を選定し、それらの直径を測定し、その平均値を求めた。
(5) Average particle size of composite particles and magnetic particles Photographs were taken at a magnification of 5,000 to 20,000 times using an SEM (scanning electron microscope: S-5000, manufactured by Hitachi High-Technologies Corporation, 20 kV), and 200 or more particles were randomly selected, their diameters were measured, and the average value was calculated.
<原料>
・TOCN:TEMPO酸化セルロースナノファイバー(第一工業製薬株式会社製「レオクリスタI-2SX」、セルロース濃度:2質量%、セルロースI型結晶構造:「あり」、数平均繊維径:4nm、平均アスペクト比:280、カルボキシ基量:1.9mmol/g)
・Fe3O4粒子1:戸田工業株式会社製(平均粒径:10nm)
・Fe3O4粒子2:戸田工業株式会社製(平均粒径:300nm)
・オキサゾリン系架橋剤(株式会社日本触媒製「エポクロス WS-700」)
<Raw materials>
TOCN: TEMPO-oxidized cellulose nanofiber ("Rheocrysta I-2SX" manufactured by Daiichi Kogyo Seiyaku Co., Ltd., cellulose concentration: 2% by mass, cellulose type I crystal structure: "present", number average fiber diameter: 4 nm, average aspect ratio: 280, carboxyl group amount: 1.9 mmol/g)
Fe3O4 particles 1: manufactured by Toda Kogyo Co., Ltd. (average particle size: 10 nm)
Fe3O4 particles 2: manufactured by Toda Kogyo Co., Ltd. (average particle size: 300 nm)
- Oxazoline crosslinking agent (Epocross WS-700, manufactured by Nippon Shokubai Co., Ltd.)
<調製例1>
TOCNとオキサゾリン系架橋剤を純水とともに混合し、超音波分散(IKA社製,T10 ULTRA-TU RRAX S0004)を20分間行って、TOCNの固形分濃度が0.08質量%、TOCNのカルボキシ基量に対しオキサゾリン系架橋剤のオキサゾリン基量が20mol%となるように水分散液を調製した。次いで、該水分散液にFe3O4粒子1を濃度が0.008質量%となるように添加し、同様の超音波分散を20分間行うことにより、TOCNとFe3O4粒子1を含む水分散液(Fe3O4/TOCN(質量比)=1/10)を調製した。得られた水分散液について、噴霧乾燥機(BUCHI(株)製、ミニスプレードライヤー B-290)を用いて噴霧乾燥を行うことにより、オキサゾリン系架橋剤にてTOCNのカルボキシ基を架橋させると同時に、TOCNとFe3O4粒子1を複合化させ、調製例1のTOCN磁性複合粒子(TEFW-0.1-10)(平均粒径:2.73μm)を得た。噴霧乾燥は、入口温度:120℃、液流量:2.5mL/min、ガス流量:6L/分とした。
<Preparation Example 1>
TOCN and the oxazoline-based crosslinking agent were mixed with pure water and subjected to ultrasonic dispersion (T10 ULTRA-TU RRAX S0004, manufactured by IKA Corporation) for 20 minutes to prepare an aqueous dispersion with a TOCN solids concentration of 0.08 mass% and an oxazoline group content of the oxazoline-based crosslinking agent of 20 mol% relative to the carboxyl group content of the TOCN. Next, Fe3O4 particles 1 were added to the aqueous dispersion to a concentration of 0.008 mass%, and similar ultrasonic dispersion was performed for 20 minutes to prepare an aqueous dispersion containing TOCN and Fe3O4 particles 1 ( Fe3O4 /TOCN (mass ratio) = 1/10). The obtained aqueous dispersion was spray-dried using a spray dryer (Mini Spray Dryer B-290, manufactured by BUCHI Corporation) to crosslink the carboxy groups of the TOCN with the oxazoline-based crosslinking agent and simultaneously composite the TOCN with Fe 3 O 4 particles 1, thereby obtaining TOCN magnetic composite particles (TEFW-0.1-10) (average particle size: 2.73 μm) of Preparation Example 1. The spray drying was performed at an inlet temperature of 120°C, a liquid flow rate of 2.5 mL/min, and a gas flow rate of 6 L/min.
<調製例2>
Fe3O4/TOCN(質量比)が3/10となるようにFe3O4粒子1の添加量を調整し、その他は調製例1と同様にして調製例2のTOCN磁性複合粒子(TEFW-0.3-10)(平均粒径:2.92μm)を得た。
<Preparation Example 2>
The amount of Fe 3 O 4 particles 1 added was adjusted so that the Fe 3 O 4 /TOCN (mass ratio) was 3/10, and the rest was the same as in Preparation Example 1 to obtain TOCN magnetic composite particles (TEFW-0.3-10) (average particle size: 2.92 μm) of Preparation Example 2.
<調製例3>
Fe3O4粒子1の代わりにFe3O4粒子2を用い、かつFe3O4/TOCN(質量比)が1/1となるようにFe3O4粒子2の添加量を調整し、その他は調製例1と同様にして調製例3のTOCN磁性複合粒子(TEFW-1-300)(平均粒径:2.59μm)を得た。
<Preparation Example 3>
The procedure was otherwise the same as in Preparation Example 1, except that Fe3O4 particles 2 were used instead of Fe3O4 particles 1, and the amount of Fe3O4 particles 2 added was adjusted so that the Fe3O4 / TOCN (mass ratio) was 1/1, to obtain TOCN magnetic composite particles (TEFW-1-300) (average particle size: 2.59 μm) of Preparation Example 3.
[アミノ基修飾TOCN磁性複合粒子の調製]
調製例1~3のTOCN磁性複合粒子について、下記(1)~(5)の手順により、エチレンジアミンを反応させてアミノ基を導入した。
(1)1.5mLマイクロチューブにTOCN磁性複合粒子5mgとN,N-ジメチルホルムアミド(DMF)1mLを入れ、DMF中にTOCN磁性複合粒子を分散させた後、室温で5分かけて磁気分離を行ってTOCN磁性複合粒子を洗浄した。磁気分離は、磁石スタンド(多摩川精機社製)にマイクロチューブを挿し、分散液中のTOCN磁性複合粒子をマイクロチューブの側面に収集させてからDMFを除去することにより行った。
(2)上記(1)の洗浄操作を3回繰り返した。
(3)塩酸1-エチル-3-(3-ジメチルアミノプロピル)カルボジイミド(EDAC)3.1mg(16μmol)を1mLのDMFに溶解させて、EDAC溶液を調製した。
(4)EDAC溶液を上記(2)で得られた磁気分離後のTOCN磁性複合粒子に添加し混合した後、エチレンジアミン0.5mg(8μmol)を添加し、超音波で分散させ、室温で2時間転倒攪拌した。
(5)転倒攪拌後に、上記(2)と同様に、DMFを用いた磁気分離洗浄を行った。これにより、下記反応式で示されるように、上記一般式(1)で表される基(式中のR1はエチレン基)を持つアミノ基修飾TOCN磁性複合粒子が得られた。
The TOCN magnetic composite particles of Preparation Examples 1 to 3 were reacted with ethylenediamine to introduce amino groups according to the following procedures (1) to (5).
(1) 5 mg of TOCN magnetic composite particles and 1 mL of N,N-dimethylformamide (DMF) were placed in a 1.5 mL microtube, and the TOCN magnetic composite particles were dispersed in the DMF. The TOCN magnetic composite particles were then washed by magnetic separation at room temperature for 5 minutes. The magnetic separation was performed by inserting the microtube into a magnet stand (manufactured by Tamagawa Seiki Co., Ltd.), allowing the TOCN magnetic composite particles in the dispersion to collect on the side of the microtube, and then removing the DMF.
(2) The washing procedure in (1) above was repeated three times.
(3) 3.1 mg (16 μmol) of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDAC) was dissolved in 1 mL of DMF to prepare an EDAC solution.
(4) The EDAC solution was added to the magnetically separated TOCN magnetic composite particles obtained in (2) above and mixed, after which 0.5 mg (8 μmol) of ethylenediamine was added, dispersed ultrasonically, and stirred by end-over-end stirring at room temperature for 2 hours.
(5) After stirring by inversion, magnetic separation and washing using DMF was carried out in the same manner as in (2) above, thereby obtaining amino group-modified TOCN magnetic composite particles having a group represented by the general formula (1) above (where R1 is an ethylene group), as shown in the following reaction formula:
[ビオチン導入複合粒子の調製]
上記で得られたアミノ基修飾TOCN磁性複合粒子を用いて、下記(1)~(3)の手順により、ビオチンが導入された複合粒子を調製した。
(1)1.5mLマイクロチューブにビオチン-NHS(Biotin N-hydroxysuccinimideester)2.7mg(8μmol)と500μLのDMFを入れて溶解させた。
(2)アミノ基修飾TOCN磁性複合粒子5mgをビオチン-NHS溶液に添加し、超音波で分散させ、室温で1時間転倒混和した。
(3)転倒混和後に、DMF1mLを用いて磁気分離洗浄を3回行った。磁気分離洗浄の方法は、アミノ基修飾TOCN磁性複合粒子の調製方法の(1)と同様である。これにより、下記反応式で示されるように、ビオチンが導入された複合粒子が得られた。
Using the amino group-modified TOCN magnetic composite particles obtained above, biotin-introduced composite particles were prepared according to the following procedures (1) to (3).
(1) 2.7 mg (8 μmol) of biotin-NHS (biotin N-hydroxysuccinimideester) was dissolved in 500 μL of DMF in a 1.5 mL microtube.
(2) 5 mg of amino group-modified TOCN magnetic composite particles were added to the biotin-NHS solution, dispersed by ultrasonic waves, and mixed by inversion at room temperature for 1 hour.
(3) After mixing by inversion, magnetic separation and washing were performed three times using 1 mL of DMF. The magnetic separation and washing method was the same as in (1) of the method for preparing amino group-modified TOCN magnetic composite particles. As a result, composite particles with biotin incorporated were obtained, as shown in the following reaction formula.
[アビジンの検出試験]
上記で得られたビオチン導入複合粒子を用いて、下記(1)~(7)の手順により、アビジンの検出試験を行った。
(1)1.5mLマイクロチューブにビオチン導入複合粒子2.5mgと1mLのバッファーを入れ、室温で5分かけて磁気分離を行ってビオチン導入複合粒子を洗浄した。磁気分離は、磁石スタンド(多摩川精機社製)にマイクロチューブを挿し、分散液中のビオチン導入複合粒子をマイクロチューブの側面に収集させてからバッファーを捨てることにより行った。バッファーとしては、1mMのMgCl2、0.1mMのZnCl2、及び0.025%オボアルブミンを含む、0.1Mグリシン-NaOHバッファー(pH10.3)を用いた。
(2)上記(1)の洗浄を3回繰り返した。
(3)洗浄後のビオチン導入複合粒子を0.2mgずつに分け、上記バッファーで5000倍、10000倍、20000倍希釈したストレプトアビジン-ALP(Promega社製)又はバッファーを200μL添加し、ローテータを用いて、室温で1時間転倒混和した。
(4)転倒混和後、室温で5分間磁気分離し、上清を全て除去してから、バッファー1mLを加えてピペッティングした。
(5)上記(4)を3回繰り返した。
(6)その後、ロシュ・ダイアグノスティックス株式会社「CDP-STAR」を150μL加え、室温にて20分間シェイカーで攪拌した。
(7)次いで、分光光度計にて460nmの発光強度を測定した。
[Avidin detection test]
Using the biotin-introduced composite particles obtained above, an avidin detection test was carried out according to the following procedures (1) to (7).
(1) 2.5 mg of biotin-incorporated composite particles and 1 mL of buffer were placed in a 1.5 mL microtube, and magnetic separation was performed at room temperature for 5 minutes to wash the biotin-incorporated composite particles. Magnetic separation was performed by inserting the microtube into a magnetic stand (manufactured by Tamagawa Seiki Co., Ltd.), allowing the biotin-incorporated composite particles in the dispersion to collect on the side of the microtube, and then discarding the buffer. The buffer used was 0.1 M glycine-NaOH buffer (pH 10.3) containing 1 mM MgCl , 0.1 mM ZnCl , and 0.025% ovalbumin.
(2) The washing procedure in (1) above was repeated three times.
(3) After washing, the biotin-introduced composite particles were divided into 0.2 mg portions, and 200 μL of streptavidin-ALP (Promega) diluted 5,000-fold, 10,000-fold, or 20,000-fold with the above buffer or buffer was added, and the mixture was mixed by inversion using a rotator at room temperature for 1 hour.
(4) After mixing by inversion, magnetic separation was performed at room temperature for 5 minutes, and after removing all of the supernatant, 1 mL of buffer was added and pipetted.
(5) The above (4) was repeated three times.
(6) Then, 150 μL of Roche Diagnostics'"CDP-STAR" was added, and the mixture was stirred with a shaker at room temperature for 20 minutes.
(7) Then, the emission intensity at 460 nm was measured using a spectrophotometer.
比較のために、市販のカルボキシ含有磁性粒子であるJSR Life Sciences社製「Magnosphere MS160/Carboxyl」を用いて、アミノ基修飾、ビオチン導入、及び、アビジン検出を行った。詳細には、10mg/mLのMagnosphere粒子500μLを1.5mLマイクロチューブに入れ、磁石スタンド(多摩川精機社製)にマイクロチューブを挿し分散液中のMagnosphere粒子をマイクロチューブの側面に収集させて液を捨て、DMF1mLを添加した。以降の操作は、[アミノ基修飾TOCN磁性複合粒子の調製]の(2)以降、[ビオチン導入複合粒子の調製]及び[アビジンの検出試験]と同様に行った。 For comparison, amino group modification, biotin introduction, and avidin detection were performed using commercially available carboxy-containing magnetic particles, "Magnosphere MS160/Carboxyl" manufactured by JSR Life Sciences. Specifically, 500 μL of 10 mg/mL Magnosphere particles were placed in a 1.5 mL microtube, the microtube was inserted into a magnetic stand (manufactured by Tamagawa Seiki Co., Ltd.), the Magnosphere particles in the dispersion were collected on the side of the microtube, the liquid was discarded, and 1 mL of DMF was added. Subsequent procedures were performed in the same manner as in (2) of [Preparation of Amino Group-Modified TOCN Magnetic Composite Particles], [Preparation of Biotin-Introduced Composite Particles], and [Avidin Detection Test].
結果は図1に示すとおりであり、実施例に係るビオチン導入複合粒子(TEFW-0.1-10、TEFW-0.3-10、TEFW-1-300)であると、アビジンを検出可能であった。 The results are shown in Figure 1. Avidin was detectable using the biotin-incorporated composite particles of the example (TEFW-0.1-10, TEFW-0.3-10, TEFW-1-300).
なお、明細書に記載の種々の数値範囲は、それぞれそれらの上限値と下限値を任意に組み合わせることができ、それら全ての組み合わせが好ましい数値範囲として本明細書に記載されているものとする。また、「X~Y」との数値範囲の記載は、X以上Y以下を意味する。 Note that the various numerical ranges described in this specification can each be combined with any upper and lower limit, and all such combinations are considered to be preferred numerical ranges and are described in this specification. Furthermore, a numerical range described as "X to Y" means between X and Y inclusive.
以上、本発明のいくつかの実施形態を説明したが、これら実施形態は、例として提示したものであり、発明の範囲を限定することは意図していない。これら実施形態は、その他の様々な形態で実施されることが可能であり、発明の要旨を逸脱しない範囲で、種々の省略、置き換え、変更を行うことができる。これら実施形態やその省略、置き換え、変更などは、発明の範囲や要旨に含まれると同様に、特許請求の範囲に記載された発明とその均等の範囲に含まれるものである。
Although several embodiments of the present invention have been described above, these embodiments are presented as examples and are not intended to limit the scope of the invention. These embodiments can be implemented in various other forms, and various omissions, substitutions, and modifications can be made without departing from the spirit of the invention. These embodiments and their omissions, substitutions, modifications, etc. are included within the scope and spirit of the invention, as well as within the scope of the invention described in the claims and their equivalents.
Claims (9)
カルボキシ基を有するセルロースナノファイバーと磁性体粒子とを含む複合粒子と、
ヒドラジン又は脂肪族ジアミンと、
カルボジイミド系縮合剤、イミダゾール系縮合剤、トリアジン系縮合剤、ホスホニウム系縮合剤、ウロニウム系縮合剤、及びハロウロニウム系縮合剤からなる群から選択される少なくとも1種の縮合剤と、
を有機溶媒中で混合することを含む、複合粒子の製造方法。 A method for producing the composite particles according to claim 1 or 2,
Composite particles containing cellulose nanofibers having carboxy groups and magnetic particles;
hydrazine or an aliphatic diamine,
at least one condensing agent selected from the group consisting of carbodiimide-based condensing agents, imidazole-based condensing agents, triazine-based condensing agents, phosphonium-based condensing agents, uronium-based condensing agents, and haluronium-based condensing agents;
in an organic solvent.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024066876 | 2024-04-17 | ||
| JP2024-066876 | 2024-04-17 | ||
| JP2025006960A JP2025163662A (en) | 2024-04-17 | 2025-01-17 | Composite particles and their manufacturing method |
| JP2025-006960 | 2025-01-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2025220405A1 true WO2025220405A1 (en) | 2025-10-23 |
Family
ID=97403336
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2025/010818 Pending WO2025220405A1 (en) | 2024-04-17 | 2025-03-19 | Composite particles and method for producing same |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2025220405A1 (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010528285A (en) * | 2007-05-23 | 2010-08-19 | ベンタナ・メデイカル・システムズ・インコーポレーテツド | Polymeric carriers for immunohistochemistry and in situ hybridization |
| JP5952522B2 (en) * | 2008-03-31 | 2016-07-13 | 旭化成株式会社 | Cellulose derivative fine particles, dispersion thereof, dispersion thereof and diagnostic agent |
| WO2019235318A1 (en) * | 2018-06-05 | 2019-12-12 | 国立大学法人福井大学 | Composition for immunoassay, diagnostic drug for immunoassay, and device for immunoassay |
| JP2020199428A (en) * | 2019-06-06 | 2020-12-17 | 凸版印刷株式会社 | Catalyst particles, method for producing catalyst particles, dried powder, fiber sheets, porous bodies |
| JP2022030885A (en) * | 2020-08-07 | 2022-02-18 | 国立大学法人広島大学 | Cellulose/magnetic substance composite particle and method for producing the same |
-
2025
- 2025-03-19 WO PCT/JP2025/010818 patent/WO2025220405A1/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010528285A (en) * | 2007-05-23 | 2010-08-19 | ベンタナ・メデイカル・システムズ・インコーポレーテツド | Polymeric carriers for immunohistochemistry and in situ hybridization |
| JP5952522B2 (en) * | 2008-03-31 | 2016-07-13 | 旭化成株式会社 | Cellulose derivative fine particles, dispersion thereof, dispersion thereof and diagnostic agent |
| WO2019235318A1 (en) * | 2018-06-05 | 2019-12-12 | 国立大学法人福井大学 | Composition for immunoassay, diagnostic drug for immunoassay, and device for immunoassay |
| JP2020199428A (en) * | 2019-06-06 | 2020-12-17 | 凸版印刷株式会社 | Catalyst particles, method for producing catalyst particles, dried powder, fiber sheets, porous bodies |
| JP2022030885A (en) * | 2020-08-07 | 2022-02-18 | 国立大学法人広島大学 | Cellulose/magnetic substance composite particle and method for producing the same |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gu et al. | Biofunctional magnetic nanoparticles for protein separation and pathogen detection | |
| CN103743722B (en) | A kind of based on nano-particle and chemiluminescent aptamer sensor and preparation method and application | |
| CN113333024B (en) | Magnetic nano enzyme material with peroxidase catalytic activity, kit for detecting norovirus and application thereof | |
| Lu et al. | Multifunctional magnetic and fluorescent core–shell nanoparticles for bioimaging | |
| Wu et al. | Immobilization of HSA on polyamidoamine-dendronized magnetic microspheres for application in direct chiral separation of racemates | |
| Huan et al. | A magnetic nanofiber-based zwitterionic hydrophilic material for the selective capture and identification of glycopeptides | |
| CN109663571A (en) | A kind of preparation method of magnetism-metal organic frame MOF material | |
| CN106552600A (en) | A kind of magnetic shell-core structure nanoparticle and preparation method and application | |
| Liu et al. | Facile synthesis of multifunctional multi-walled carbon nanotube for pathogen Vibrio alginolyticus detection in fishery and environmental samples | |
| Kumar et al. | Biofunctional magnetic nanotube probe for recognition and separation of specific bacteria from a mixed culture | |
| CN1268930C (en) | Assembled magnetic composite micro particle, and its preparing method and use | |
| WO2025220405A1 (en) | Composite particles and method for producing same | |
| CN113634226B (en) | Fe3O4/GO composite nanomaterial and its preparation method and application | |
| JP2025163662A (en) | Composite particles and their manufacturing method | |
| CN117324621B (en) | Surface modified gold magnetic nanoparticles and preparation method and application thereof | |
| CN116908154B (en) | Rapid detection method for ciprofloxacin in meat product based on enzyme-linked up-conversion fluorescence and potassium titanate system | |
| Nekounam et al. | Application of functional magnetic nanoparticles for separation of target materials: a review | |
| WO2025220404A1 (en) | Composite particles and method for producing same | |
| Roque et al. | Antibody immobilization on magnetic particles | |
| JP2025163661A (en) | Composite particles and their manufacturing method | |
| CN115792207B (en) | Single-molecule detection method based on fulvene compounds | |
| JP2010066200A (en) | Temperature-responsive magnetic fine grains having surface modified by oleophilic molecule, and composition forming ribosome-like structure containing the fine grains and amphipathic molecule | |
| JP7649508B2 (en) | Cellulose/magnetic composite particles and method for producing same | |
| CN104209087A (en) | Monodispersed nano magnetic bead used for rapid sample pretreatment and preparation method thereof | |
| CN120796521A (en) | Composite probe for detecting salmonella enteritidis and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 25789797 Country of ref document: EP Kind code of ref document: A1 |